Myriad Genetics reported $-2100000 in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agilent A:US $ 435M 40M
Becton, Dickinson and BDX:US $ 1094M 316M
Bio Rad Laboratories BIO:US $ 159.37M 49.79M
Biocept BIOC:US $ -1.4M 4.43M
Bruker BRKR:US $ 111.2M 4.2M
Danaher DHR:US $ 2530M 31M
Fluidigm FLDM:US $ -13.15M 2.04M
Genmark Diagnostics GNMK:US $ -0.46M 1.15M
Hologic HOLX:US $ 463.4M 415.5M
Illumina ILMN:US $ 236M 5M
Johnson & Johnson JNJ:US $ 8103M 786M
Luminex LMNX:US $ 21.3M 3.09M
Mettler Toledo International MTD:US 269.24M 45.51M
Myriad Genetics MYGN:US $ -2.1M 26.2M
Nanostring Technologies NSTG:US $ -24.2M 0.23M
Oxford Immunotec Global OXFD:US $ 0.79M 10.16M
Perkinelmer PKI:US $ 398.96M 158.86M
Quest Diagnostics DGX:US $ 654M 128M
Quidel QDEL:US $ 38.82M 198.8M
Repligen RGEN:US $ 60.44M 10.97M
Thermo Fisher Scientific TMO:US $ 2942M 766M
Veracyte VCYT:US $ 5.73M 13.49M
Waters WAT:US $ 229.24M 26.61M